ImmuCell Corp
NASDAQ:ICCC

Watchlist Manager

ImmuCell Corp

NASDAQ:ICCC

Watchlist

Dividends

Price: 3.61 USD -1.63% Market Closed

Market Cap: 28.3m USD

Have any thoughts about
ImmuCell Corp?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Fubotv Inc NYSE:FUBO	Media
US	Bank of America Corp NYSE:BAC	Banking
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Uber Technologies Inc NYSE:UBER	Road & Rail
CN	NIO Inc NYSE:NIO	Automobiles
US	Fluor Corp NYSE:FLR	Construction
US	Jacobs Engineering Group Inc NYSE:J	Professional Services
US	TopBuild Corp NYSE:BLD	Consumer products
US	Abbott Laboratories NYSE:ABT	Health Care
US	Chevron Corp NYSE:CVX	Energy
US	Occidental Petroleum Corp NYSE:OXY	Energy
US	Matrix Service Co NASDAQ:MTRX	Construction
US	Automatic Data Processing Inc NASDAQ:ADP	Technology
US	Qualcomm Inc NASDAQ:QCOM	Semiconductors
US	PayPal Holdings Inc NASDAQ:PYPL	Technology
US	Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 3.61 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

ICCC Alert

ImmuCell Corp

3.61

-0.06 (-1.63%)

52 Week Range	3.53 5.4765
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	PayPal Holdings Inc NASDAQ:PYPL	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

ImmuCell Corp

What unique competitive advantages
does ImmuCell Corp hold over its rivals?

What risks and challenges
does ImmuCell Corp face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of ImmuCell Corp.

What unique competitive advantages
does ImmuCell Corp hold over its rivals?

What risks and challenges
does ImmuCell Corp face in the near future?

Has there been any significant insider trading activity
in ImmuCell Corp recently?

Summarize the latest earnings call
of ImmuCell Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for ImmuCell Corp.

Provide P/S
for ImmuCell Corp.

Provide P/E
for ImmuCell Corp.

Provide P/OCF
for ImmuCell Corp.

Provide P/FCFE
for ImmuCell Corp.

Provide P/B
for ImmuCell Corp.

Provide EV/S
for ImmuCell Corp.

Provide EV/GP
for ImmuCell Corp.

Provide EV/EBITDA
for ImmuCell Corp.

Provide EV/EBIT
for ImmuCell Corp.

Provide EV/OCF
for ImmuCell Corp.

Provide EV/FCFF
for ImmuCell Corp.

Provide EV/IC
for ImmuCell Corp.

Show me price targets
for ImmuCell Corp made by professional analysts.

What are the Revenue projections
for ImmuCell Corp?

How accurate were the past Revenue estimates
for ImmuCell Corp?

What are the Net Income projections
for ImmuCell Corp?

How accurate were the past Net Income estimates
for ImmuCell Corp?

What are the EPS projections
for ImmuCell Corp?

How accurate were the past EPS estimates
for ImmuCell Corp?

What are the EBIT projections
for ImmuCell Corp?

How accurate were the past EBIT estimates
for ImmuCell Corp?

Compare the revenue forecasts
for ImmuCell Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of ImmuCell Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of ImmuCell Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of ImmuCell Corp compared to its peers.

Compare the P/E ratios
of ImmuCell Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing ImmuCell Corp with its peers.

Analyze the financial leverage
of ImmuCell Corp compared to its main competitors.

Show all profitability ratios
for ImmuCell Corp.

Provide ROE
for ImmuCell Corp.

Provide ROA
for ImmuCell Corp.

Provide ROIC
for ImmuCell Corp.

Provide ROCE
for ImmuCell Corp.

Provide Gross Margin
for ImmuCell Corp.

Provide Operating Margin
for ImmuCell Corp.

Provide Net Margin
for ImmuCell Corp.

Provide FCF Margin
for ImmuCell Corp.

Show all solvency ratios
for ImmuCell Corp.

Provide D/E Ratio
for ImmuCell Corp.

Provide D/A Ratio
for ImmuCell Corp.

Provide Interest Coverage Ratio
for ImmuCell Corp.

Provide Altman Z-Score Ratio
for ImmuCell Corp.

Provide Quick Ratio
for ImmuCell Corp.

Provide Current Ratio
for ImmuCell Corp.

Provide Cash Ratio
for ImmuCell Corp.

What is the historical Revenue growth
over the last 5 years for ImmuCell Corp?

What is the historical Net Income growth
over the last 5 years for ImmuCell Corp?

What is the current Free Cash Flow
of ImmuCell Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for ImmuCell Corp.

EV/EBITDA
Enterprise Value to EBITDA

-31.8

Current

-11.7

Median

4.5

Industry

Lower than median

Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA

-31.8

Enterprise Value

36.8m USD

EBITDA

-1.2m USD

All Countries

Forward Multiples

			Market Cap	EV/EBITDA
US		ImmuCell Corp NASDAQ:ICCC	28.3m USD	-31.8
US		Abbvie Inc NYSE:ABBV	358.9B USD	16.5
US		Amgen Inc NASDAQ:AMGN	172.7B USD	19.5
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	122.8B USD	26.7
US		Gilead Sciences Inc NASDAQ:GILD	110.7B USD	9.9
US	E	Epizyme Inc F:EPE	94.1B EUR	-535.9
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	92B USD	18.2
AU		CSL Ltd ASX:CSL	138.7B AUD	21.2
US	S	Seagen Inc F:SGT	39.3B EUR	-61.3
US		Alnylam Pharmaceuticals Inc NASDAQ:ALNY	34.2B USD	206.3
NL		argenx SE XBRU:ARGX	32B EUR	-100.5

				EBITDA Growth
US		ImmuCell Corp NASDAQ:ICCC	Average EV/EBITDA: 45.5 Negative Multiple: -31.8	N/A
US		Abbvie Inc NYSE:ABBV	16.5	28%
US		Amgen Inc NASDAQ:AMGN	19.5	64%
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	26.7	37%
US		Gilead Sciences Inc NASDAQ:GILD	9.9	9%
US	E	Epizyme Inc F:EPE	Negative Multiple: -535.9	N/A
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	18.2	53%
AU		CSL Ltd ASX:CSL	21.2	42%
US	S	Seagen Inc F:SGT	Negative Multiple: -61.3	N/A
US		Alnylam Pharmaceuticals Inc NASDAQ:ALNY	206.3	N/A
NL		argenx SE XBRU:ARGX	Negative Multiple: -100.5	N/A

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBITDA

N/A

2-Years Forward

EV/EBITDA

N/A

3-Years Forward

EV/EBITDA

N/A

ImmuCell Corp
NASDAQ:ICCC

EV/EBITDA
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

ImmuCell Corp NASDAQ:ICCC

EV/EBITDA Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

ImmuCell Corp
NASDAQ:ICCC

EV/EBITDA
Enterprise Value to EBITDA